Syncom Formulations India Balance Sheet Annual

Trade

BSE: 524470 | NSE: SYNCOMF | ISIN: INE312C01025 | Sector: Biotechnology & Drugs

19.58 +0.07 (0.36%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	4.48	7.98	0.08	61.45
Cash Equivalents	63.38	0.53	0.30	2.75
Short Term Investments	67.82	66.01	47.35	14.21
Cashand Short Term Investments	135.68	74.52	47.74	78.41
Accounts Receivable- Trade Net	103.30	75.61	67.55	74.82
Total Receivables Net	107.58	83.25	67.55	74.82
Total Inventory	21.08	23.40	19.51	22.56
Other Current Assets Total	10.44	0.16	5.01	14.06
Total Current Assets	274.78	181.69	139.80	189.84
Property/ Plant/ Equipment Total- Net	72.31	68.81	52.71	44.58
Intangibles Net	0.11	0.18	0.10	0.12
Long Term Investments	56.74	124.90	113.10	56.00
Note Receivable- Long Term	0.52	0.50	0.34	0.34
Other Long Term Assets Total	0.21	1.76	2.19	0.76
Total Assets	404.66	377.83	308.24	291.65
Accounts Payable	24.14	20.45	13.79	29.30
Notes Payable/ Short Term Debt	72.49	83.18	57.79	62.09
Other Currentliabilities Total	9.89	8.95	6.67	5.31
Total Current Liabilities	106.52	113.16	78.26	96.70
Total Debt	72.49	83.18	57.79	62.09
Deferred Income Tax	4.98	4.42	4.58	4.44
Other Liabilities Total	5.02	4.23	3.19	2.93
Total Liabilities	116.52	121.82	86.02	104.07
Common Stock Total	94.00	94.00	86.25	79.00
Retained Earnings( Accumulated Deficit)	194.14	137.63	135.98	108.59
Total Equity	288.14	256.01	222.22	187.58
Total Liabilities Shareholders' Equity	404.66	377.83	308.24	291.65
Total Common Shares Outstanding	94.00	94.00	86.25	79.00
Tangible Book Valueper Share Common Eq	3.06	2.72	2.58	2.37
Prepaid Expenses	-	0.35	-	-
Property/ Plant/ Equipment Total- Gross	-	126.81	6.20	0.38
Accumulated Depreciation Total	-	-58.00	-	-
Accrued Expenses	-	0.58	-	-
Total Long Term Debt	-	0.00	0.00	0.00
Additional Paid- In Capital	-	24.38	-	-